Voyager Therapeutics
Voyager Therapeutics, a Cambridge‑based biotech, develops gene and antibody therapies for neurodegenerative disorders, led by a Phase 1b anti‑tau drug for Alzheimer’s. It partners with major pharma and focuses on high‑impact markets.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 172
- HQ: Lexington
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.